INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530 | +19.6% | 21 | 0.0% | 0.00% | – |
| Q2 2023 | $443 | +23.7% | 21 | 0.0% | 0.00% | – |
| Q1 2023 | $358 | -14.8% | 21 | 0.0% | 0.00% | – |
| Q4 2022 | $420 | – | 21 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 21 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 21 | -41.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 36 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 36 | -36.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 57 | -3.4% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 59 | +7.3% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |